Stock Summary
- Company Name / ASX Ticker: CSL Limited (ASX: CSL)
- Sector: Healthcare Technology
- Share Price: $198.85 (As of 1 October 2025)
- Target Price Range: $214-$230
- Recent Performance: Delivered 5% revenue growth in FY25 while NPAT rose ~17% (constant currency), showing improving operating leverage.
Business Overview - ASX: CSL
- CSL Behring (plasma & recombinant therapies): Immunoglobulins, albumin and specialty products for rare/serious diseases. Vertically integrated. . .
Gain full access to all our premium investment intelligence
Plans from $9.99 per week, cancel anytime.
Subscribe or upgrade to Investor Starter to view this content
Already a member? Sign in